Research Article

KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer

Figure 2

Correlation between the expression of KNSTRN and TNM tumor stages. (a–e) Determination of pan-cancer KNSTRN expression in four different TNM stages from TCGA database. The left panel represents stage I-IV and the right panel merges stage I with stage II, and merges stage III with stage IV. ; ns: not significant.
(a)
(b)
(c)
(d)
(e)